Modulation of naive CD4 T cell activation with altered peptide ligands: The nature of the peptide and presentation in the context of costimulation are critical for a sustained response

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3698-3704

  Rogers, Paul R ^a   Grey, Howard M ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CYTOCHROME C; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; DOSE RESPONSE; HYPOTHESIS; IMMUNOMODULATION; MOTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; COLUMBIDAE; CYTOCHROME C GROUP; INTERLEUKIN-2; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MOTHS; PEPTIDES;

EID: 0032522809     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Croft, M. 1994. Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 6:431.
2. Croft, M., and C. Dubey. 1997. Accessory molecule and costimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 17:89.
3. Kakiuchi, T., R. W. Chesnut, and H. M. Grey. 1983. B cells as antigen-presenting cells: the requirement for B cell activation. J. Immunol. 131:109.
4. Inaba, K., and R. M. Steinman. 1984. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J. Exp. Med. 160:1717.
5. + T cells in vitro: characteristics and antigen-presenting cell requirements J. Exp. Med. 176:1431.
6. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
7. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
8. + T cells. J. Exp. Med. 179:1539.
9. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
10. Jaiswal, A. I., C. Dubey, S. L. Swain, and M. Croft. 1996. Regulation of CD40-ligand expression on naive CD4 T cells: a role for T cell receptor but no costimulatory signals. Int. Immunol. 8:275.
11. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
12. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
13. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
14. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
15. Sligh, J. J., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith, A. Bradley, and A. L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90:8529.
16. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H. M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413.
17. Jameson, S. C, and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1.
18. Sloan-Lancaster, J., and P. M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103.
19. Alexander, J., K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F. C. A. Gaeta, S. M. Colon, H. M. Grey, and A. Sette. 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150:1.
20. De Magistris, M., J. Alexander, M. Coggeshall, A. Altman, F. C. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
21. Evavold, B. D., L. J. Sloan, B. L. Hsu, and P. M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
22. La Face, D., C. Couture, K. Anderson, G. Shih, J. Alexander, A. Sette. T. Mustelin, A. Altman, and H. M. Grey. 1997. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158:2057.
23. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
24. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
25. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195
26. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
27. Sette, A., S. Southwood, D. O'Sullivan, F. C. Gaeta, J. Sidney, and H. M. Grey. 1992. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148:844.
28. Reav, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements B to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
29. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
30. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
31. Lyons, D. S, S. A. Lieberman, J. Hampl, J. J. Boniface, Y. Chien, L. J Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
32. Rabinowitz, J. D., C. Beeson, D. S. Lyons, M. M. Davis, and H. M. McConnell. 1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA 93:1401.
33. Mannie, M. D., J. M. Rosser, and G. A. White. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4: evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154:2642.
34. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997 The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonsit partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185. 219.
35. Madrenas J , R. H. Schwaertz, and R. N. Germain. 1996. Interleukin 2 production. not the pattern of early T-cell antigen receptor-dependent tyrosme phosphoryla-tion, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA 93:9736.
36. Rabinowitz, J .D., C. Beeson, C. Wulfing, K. Tate, P. M. Allen, M. M. Davis, and H. M. McConnell. 1996. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 5:125.